Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Other(3)

Detailed Status

unknown3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

unknown3100%

Recent Activity

0 active trials
Showing 3 of 3
unknownnot_applicable

Development of Pharmacogenomic Method to Predict Antidepressant Responsiveness

NCT00817011
unknownnot_applicable

Predict Antidepressant Responsiveness Using Pharmacogenomics

NCT01228357
unknownnot_applicable

Pharmacogenomic Study to Predict Antidepressant Responsiveness in Depressed Patients

NCT00817375

Clinical Trials (3)

Showing 3 of 3 trials
NCT00817011Not Applicable

Development of Pharmacogenomic Method to Predict Antidepressant Responsiveness

Unknown
NCT01228357Not Applicable

Predict Antidepressant Responsiveness Using Pharmacogenomics

Unknown
NCT00817375Not Applicable

Pharmacogenomic Study to Predict Antidepressant Responsiveness in Depressed Patients

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3